Orthofix Medical Inc. (NASDAQ:OFIX) Stock Has Consensus Target Price of $14.75 According to Brokerages

Orthofix Medical Inc. (NASDAQ:OFIX) has received an average recommendation of “Hold” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $14.75.

A number of research analysts recently commented on OFIX shares. Weiss Ratings cut Orthofix Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, October 2nd. Barrington Research upped their price objective on shares of Orthofix Medical from $15.00 to $17.00 and gave the stock an “outperform” rating in a research report on Monday, July 6th. Finally, Canaccord Genuity Group cut their price objective on shares of Orthofix Medical from $18.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, August 10th.

Hedge Funds Weigh In On Orthofix Medical

Hedge funds and other institutional investors have recently made changes to their positions in the company. Moore Capital Management LP acquired a new stake in shares of Orthofix Medical in the 2nd quarter valued at $781,000. Paradigm Capital Management Inc. NY bought a new position in shares of Orthofix Medical in the 2nd quarter valued at $30,167,000. Juniper Investment Company LLC increased its stake in shares of Orthofix Medical by 23.3% in the 4th quarter. Juniper Investment Company LLC now owns 3,510,333 shares of the medical device company’s stock valued at $53,217,000 after purchasing an additional 663,278 shares during the last quarter. BlackRock Inc. acquired a new position in shares of Orthofix Medical during the 2nd quarter worth $30,405,000. Finally, Engine Capital Management LP raised its holdings in shares of Orthofix Medical by 3.2% during the 1st quarter. Engine Capital Management LP now owns 4,390,779 shares of the medical device company’s stock worth $50,362,000 after buying an additional 137,858 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Trading Down 0.2%

Shares of NASDAQ:OFIX opened at $9.26 on Friday. The business’s 50 day simple moving average is $9.52 and its 200 day simple moving average is $10.56. Orthofix Medical has a 1 year low of $8.50 and a 1 year high of $16.99. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.84 and a quick ratio of 1.67. The company has a market capitalization of $377.16 million, a P/E ratio of -6.01 and a beta of 0.62.

Orthofix Medical (NASDAQ:OFIX) last announced its quarterly earnings data on Wednesday, August 5th. The medical device company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.02. The firm had revenue of $210.93 million during the quarter, compared to analysts’ expectations of $209.28 million. Orthofix Medical had a negative return on equity of 14.05% and a negative net margin of 7.41%. On average, research analysts anticipate that Orthofix Medical will post -1.29 EPS for the current fiscal year.

Orthofix Medical Company Profile

Orthofix Medical Inc (NASDAQ: OFIX) is a medical device company focused on orthopedic and spine care. Its products are designed to support the treatment of spinal conditions, musculoskeletal disorders, fractures and other orthopedic injuries.

The company offers spinal implants and instrumentation, bone graft substitutes and biologic solutions, and technologies intended to support bone growth and healing. Orthofix also provides products for limb reconstruction and extremity fixation, including systems used in the treatment of complex fractures and deformities.

Orthofix markets its products to hospitals, surgeons and other healthcare providers in the United States and international markets.